ORGO - Organogenesis Holdings GAAP EPS of $0.00 revenue of $116.9M guidance below consensus
- Organogenesis Holdings press release ( NASDAQ: ORGO ): Q3 GAAP EPS of $0.00.
- Revenue of $116.9M (+2.7% Y/Y).
- For FY22, Net revenue of between $448 million and $465 million is expected, vs. consensus of $476.85M.
For further details see:
Organogenesis Holdings GAAP EPS of $0.00, revenue of $116.9M, guidance below consensus